| |
| |
SPOT ON
|
| |
Candesartan (e.g. ATACAND) in heart failure? |
 |
Perindopril (COVERSUM) in coronary heart disease? |
| |
| |
NEW ON THE MARKET
|
| |
Not at all new: Escitalopram (CIPRALEX) |
| |
| |
TREATMENT RECOMMENDATION
|
| |
Long-term anticoagulation in idiopathic venous thromboembolism
|
| |
| |
QUALITY ASSESSMENT
|
| |
Hydrochlorothiazide and paracetamol preparations
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
GUKOKINE for diabetes?
Old registered drugs and what happens then
Proton pump inhibitor via PEG tube?
Expired drugs
ISCOVER/PLAVIX more expensive
|
| |
| |
IN BRIEF
|
| |
Beware of "drug holidays" in patients with multidrug-resistant HI virus
High-dose dexamethasone (e.g. FORTECORTIN) therapy for idiopathic thrombopenia?
Chronic myeloid leukaemia: Survival with imatinib (GLIVEC)
Hot flushes: Phytoestrogens from red clover vs placebo
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Granulomas after intradermal injection of DERMALIVE
|
| |
| |
SIDE EFFECTS
|
| |
Bicalutamide (CASODEX) in patients with localized prostate cancer
Sibutramin (REDUCTIL): Market withdrawal warranted
|
| |